Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Yongtai Pharmaceutical is a specialized pharmaceutical company and a key subsidiary of Zhejiang Yongtai Technology. The company focuses on the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms. Its product portfolio primarily covers therapeutic areas such as cardiovascular health, diabetes management, and central nervous system disorders. Yongtai Pharmaceutical operates high-standard manufacturing facilities that comply with international GMP standards, serving both domestic Chinese and global markets. The company also functions as a CDMO, providing chemical synthesis and production services to global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Yongtai Pharmaceutical.